STIM
-
Biologics
MedTech Breakthrough Recognizes STIM onTrack for Bone Growth Therapy as Best Patient Engagement Mobile App
LEWISVILLE, TEXAS, May 4, 2023 /OrthoSpineNews/ – Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced…
Read More » -
Regulatory
Orthofix Announces FDA Approval of STIM onTrack 2.1 Mobile App for Bone Growth Stimulators
February 13, 2020 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies,…
Read More » -
Spine
Orthofix Wins 2017 Spine Technology Award for STIM onTrack Mobile App
October 25, 2017 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical device company, today announced that its STIM onTrack™ mobile…
Read More »